NORMAL SITUATION

Pharma Louvranges

Export PDF

Financial year 2021 · closed on 31/12/2021

Net result

-92,3 k €

-1450.1% YoY

Gross margin

442,2 k €

-5.3% YoY

Equity

-287,8 k €

-47.2% YoY

Workforce

4,0 ETP

+14.3% YoY

Company — Normal situation.

What does Pharma Louvranges do?

Pharma Louvranges is a company registered in Belgium. It employs on average 4,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0474.483.121

Legal form

Private company with limited liability

Contributed capital

6 321,28 €

Latest accounts

31/12/2021

Average workforce

4,0 ETP

Joint committees (1)

Signals

Good liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 15 financial years

	2021		2020		2019		2018		2017		2016		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	442,2 k €	-5.3%	467,1 k €	+12.5%	415,3 k €	-3.9%	432,2 k €	+5.6%	409,4 k €	-16.6%	490,9 k €	+104%	240,1 k €	-3.9%	249,7 k €	+5.4%	236,9 k €	+26.4%	187,4 k €	-6.9%	201,3 k €	+32.0%	152,5 k €	+319%	36,4 k €	+84.0%	19,8 k €	+79.8%	11 k €
EBITDA	210,2 k €	-22.4%	270,9 k €	+38.7%	195,3 k €	+4.2%	187,4 k €	-15.1%	220,8 k €	-39.6%	365,3 k €	+83.6%	199 k €	-1.5%	202 k €	+9.7%	184,1 k €	+31.7%	139,8 k €	-9.9%	155,1 k €	+46.1%	106,1 k €	+3663%	-3 k €	-162%	4,8 k €	+27.5%	3,8 k €
Operating result	-66,8 k €	-200%	66,7 k €	+542%	-15,1 k €	+44.3%	-27,1 k €	-234%	20,2 k €	-88.7%	178,5 k €	+13.5%	157,3 k €	-1.8%	160,3 k €	+14.4%	140,1 k €	+23.8%	113,2 k €	-11.8%	128,4 k €	+67.8%	76,5 k €	+658%	-13,7 k €	-1230%	1,2 k €	+847%	128 €
Net result	-92,3 k €	-1450%	6,8 k €	+111%	-61,7 k €	-1.2%	-61 k €	+11.7%	-69 k €	-283%	37,8 k €	-34.0%	57,3 k €	+3.0%	55,6 k €	+41.5%	39,3 k €	+104%	19,3 k €	-43.1%	33,9 k €	+542%	-7,7 k €	+57.2%	-17,9 k €	-1844%	-921,4 €	-0.3%	-919 €
Balance sheet
Equity	-287,8 k €	-47.2%	-195,5 k €	+3.4%	-202,4 k €	-43.9%	-140,7 k €	-76.5%	-79,7 k €	-648%	-10,7 k €	-106%	173,4 k €	+49.4%	116,1 k €	+92.1%	60,4 k €	+187%	21,1 k €	+1074%	1,8 k €	+106%	-32,1 k €	-31.4%	-24,4 k €	-276%	-6,5 k €	-16.5%	-5,6 k €
Total assets	834,7 k €	-21.7%	1,1 M €	-9.2%	1,2 M €	-16.2%	1,4 M €	-18.5%	1,7 M €	+6.7%	1,6 M €	-1.4%	1,6 M €	-2.8%	1,7 M €	-2.4%	1,7 M €	-0.8%	1,7 M €	-2.6%	1,8 M €	-1.6%	1,8 M €	+30.4%	1,4 M €	+8658%	15,9 k €	+31.5%	12,1 k €
Cash	83,7 k €	+41.5%	59,2 k €	+2.3%	57,9 k €	-76.7%	247,9 k €	+249%	71 k €	-72.2%	255,8 k €	+505%	42,3 k €	-10.9%	47,5 k €	+3.6%	45,8 k €	+2.3%	44,8 k €	-2.5%	45,9 k €	-1.3%	46,5 k €	+466%	8,2 k €	+33.8%	6,1 k €	+230%	1,9 k €
Debts	1,1 M €	-11.0%	1,3 M €	-8.3%	1,4 M €	-10.8%	1,5 M €	-14.4%	1,8 M €	+12.1%	1,6 M €	+11.0%	1,4 M €	-6.7%	1,6 M €	-5.9%	1,6 M €	-3.9%	1,7 M €	-3.7%	1,8 M €	-3.5%	1,8 M €	+30.4%	1,4 M €	+6223%	22,4 k €	+26.7%	17,7 k €
Other
Workforce	4,0 ETP	+14.3%	3,5 ETP	+12.9%	3,1 ETP	-29.5%	4,4 ETP	+63.0%	2,7 ETP	+35.0%	2,0 ETP	+100%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	+233%	0,3 ETP		–

Governance

Board of directors

Seen on filing of 31/12/2021 · 1 active · 3 ended

Active mandates

peeters mathieu management

Mandate · 0876.728.461

Active

Ended mandates

CIPANGO

Director · since 01 octobre 2017 · 0430.115.717

Represented by Thierry Masquelin

Ended

CIPANGO

Manager · since 01 octobre 2017 · 0430.115.717

Represented by Thierry Masquelin

Ended

Michel De Potter

Mandate

Ended

Annual accounts

Full financial information

	2021	2020	2019	2018	2017	2016
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2021	01/01/2020	01/01/2019	01/01/2018	01/01/2017	01/01/2016
Closing of the financial year	31/12/2021	31/12/2020	31/12/2019	31/12/2018	31/12/2017	31/12/2016
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2022	27/07/2021	29/06/2020	20/05/2019	16/07/2018	01/06/2017
General meeting	30/05/2022	11/05/2021	12/05/2020	14/05/2019	08/05/2018	12/05/2017
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2021	30/05/2022	29/06/2022	French	PDF
Abridged model	31/12/2020	11/05/2021	27/07/2021	French	PDF
Abridged model	31/12/2019	12/05/2020	29/06/2020	French	PDF
Abridged model	31/12/2018	14/05/2019	20/05/2019	French	PDF
Abridged model	31/12/2017	08/05/2018	16/07/2018	French	PDF
Abridged model	31/12/2016	12/05/2017	01/06/2017	French	PDF
Abridged model	31/12/2015	13/05/2016	20/06/2016	French	PDF
Abridged model	31/12/2014	12/05/2015	18/05/2015	French	PDF
Abridged model	31/12/2013	13/05/2014	15/05/2014	French	PDF
Abridged model	31/12/2012	14/05/2013	21/05/2013	French	PDF
Abridged model	31/12/2011	08/05/2012	04/06/2012	French	PDF
Abridged model	31/12/2010	10/05/2011	25/05/2011	French	PDF
Abridged model	31/12/2009	11/05/2010	15/06/2010	French	PDF
Abridged model	31/12/2008	12/05/2009	25/05/2009	French	PDF
Abridged model	31/12/2007	13/05/2008	28/05/2008	French	PDF
Abridged model	31/12/2006	08/05/2007	01/06/2007	French	PDF
Abridged model	31/12/2005	09/05/2006	30/05/2006	French	PDF
Abridged model	31/12/2004	10/05/2005	02/06/2005	French	PDF
Abridged model	31/12/2003	11/05/2004	10/06/2004	French	PDF
Abridged model	31/12/2002	13/05/2003	13/06/2003	French	PDF
Abridged model	31/12/2001	14/05/2002	09/09/2002	French	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2021 · 1 active · 3 ended

Active mandates

peeters mathieu management

Mandate · 0876.728.461

Active

Ended mandates

CIPANGO

Director · since 01 octobre 2017 · 0430.115.717

Represented by Thierry Masquelin

Ended

CIPANGO

Manager · since 01 octobre 2017 · 0430.115.717

Represented by Thierry Masquelin

Ended

Michel De Potter

Mandate

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2021
Annual accounts 2021-92,3 k €↓
2020
Annual accounts 20206,8 k €↑
2019
Annual accounts 2019-61,7 k €↓
2018
Annual accounts 2018-61 k €↑
2017
Annual accounts 2017-69 k €↓
2016
Annual accounts 201637,8 k €↓
2014
Annual accounts 201457,3 k €↑
2013
Annual accounts 201355,6 k €↑
2012
Annual accounts 201239,3 k €↑
2011
Annual accounts 201119,3 k €↓
2010
Annual accounts 201033,9 k €↑
2009
Annual accounts 2009-7,7 k €↑
2008
Annual accounts 2008-17,9 k €↓
2007
Annual accounts 2007-921,4 €↓
2006
Annual accounts 2006-919 €

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Pharma Louvranges

Overview

What does Pharma Louvranges do?

Trend over 15 financial years

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Similar companies

Similar companies

Timeline